Rapid Readout: Angiopoietin-2 (Ang2) Inhibition in the Treatment of Diabetic Macular Edema and Exudative AMD.

home / rapid-readouts / rapid-readout-angiopoietin-2-ang2-inhibition-in-the-treatment-of-diabetic-macular-edema-and-exudative-amd-

Anat Loewenstein, MD, MHA, discusses data from the Angiogenesis, Exudation, and Degeneration 2021 Virtual Symposium on angiopoietin-2/VEGF-A dual inhibition in the management of diabetic macular edema and exudative age-related macular degeneration.

Angiogenesis 2021 Virtual Symposium Takeaways & Final Thoughts

EP. 1: Angiogenesis 2021 Virtual Symposium Takeaways & Final Thoughts

Anat Loewenstein, MD, MHA
March 22nd 2021

Angiogenesis, Exudation, and Degeneration 2021 Virtual Symposium highlights and thoughts on current treatments options for DME and exudative AMD are discussed. 

Ang-2/VEGF-A Inhibition Synergistic Effect in DME and AMD

EP. 2: Ang-2/VEGF-A Inhibition Synergistic Effect in DME and AMD

Anat Loewenstein, MD, MHA
March 22nd 2021

Anat Loewenstein, MD, MHA, explores dual Ang-2/VEGF-A inhibition in the management of diabetic macular edema and exudative age-related macular degeneration.

© 2024 MJH Life Sciences

All rights reserved.